CROI 2019 Program and Conference Information

Poster Sessions

535

INI-RESISTANCE DYNAMICS FROM2007 TO 2017 IN ITALIAN CLINICAL ISOLATES Daniele Armenia, Caterina Gori, Ada Bertoli, Vanni Borghi, Alessandra Latini, Roberta Gagliardini, Miriam Lichtner, Federica Forbici, Francesco Montella, Cristina Mussini, Massimo Andreoni, Andrea Antinori, Francesca Ceccherini Silberstein, Carlo Federico Perno, Maria M. Santoro ANTIRETROVIRAL DRUG RESISTANCE IN PATIENTS RECEIVING CARE AT ETHIOPIANHEALTH CENTERS Anton Reepalu, Dawit A. Assefa Arimide, Per Bjorkman, Patrik Medstrand BASELINE HIV DRUG RESISTANCE AMONG TREATMENT-NAIVE PATIENTS IN ESWATINI, MAXART TRIAL Shaukat Khan, Anita Hettema, Fiona Walsh, Sikhathele Mazibuko, Velephi Okello, Charlotte Lejeune, Jilian Sacks, Michael R. Jordan, John Koo, P. Richard Harrigan, Chanson J. Brumme, Hope R. Lapointe MODELING THE IMPACT OF DOLUTEGRAVIR INTRODUCTION ON NNRTI RESISTANCE IN SOUTH AFRICA Anthony Hauser, Katharina Kusejko, Leigh F. Johnson, Huldrych F. Günthard, Julien Riou, Gilles Wandeler, Matthias Egger, Roger Kouyos Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Ernesto Claar, Ivan Gentile, Paola Pierri, Lorenzo Antonio Surace, Filomena Morisco, Paolo Tundo, Giuseppina Brancaccio, Nicola Coppola, Annamaria Longo, Mario Masarone GRAZOPREVIR/ELBASVIR FOR HCV-INFECTED PWID IN REAL-WORLD SETTINGS: THE ZEPALIVE STUDY Juan Macías, Luis Morano, Francisco Téllez, Maria J. Rios-Villegas, Rafael Granados, Antonio Collado, Carlos Galera, Francisco Vera, Dolores Merino, Ignacio Santos, Oscar Rincón, Juan A. Pineda, for the HEPAVIR and GEHEP study groups. GEHEP-001 project REAL-WORLD DATA ON ELBASVIR/GRAZOPREVIR FOR HCV INFECTION INHIV/NON-HIV PATIENTS Maria Luisa Montes, Juan Berenguer, Ángela Gil-Martín, Adriana Ahumada, Teresa Aldámiz-Echevarría, José L. Calleja, Agustín Albillos, Antonio Olveira, Maria Jesus Tellez Molina, Lourdes Domínguez- Domínguez, Conrado Fernández Rodríguez, José Sanz, Inma Jarrin, María J. Calvo, Juan González-García EFFECTIVENESS OF HEPATITIS C TREATMENT INHIV/HCV COINFECTED PATIENTS INMYANMAR Derek Johnson, Htay Thet Mar, Phone Thit, Tobias Homan, Phyu Ei Mon, Kyi Pyar Soe, Win Le Shwe Sin Ei, Khin Sanda Aung, Thin Thin Thwe, Nyan Lynn Tun, Kyaw Zay Lwin, Aude Nguyen, Anne Loarec HCV LATE RELAPSE IN PATIENTSWITH DIRECTLY ACTING ANTIVIRAL–RELATED SVR 12 Carmine Minichini, Mariantonietta Pisaturo, Mario Starace, Caroprese Mara, Margherita Macera, Giuseppina Brancaccio, Stefania De Pascalis, Alfonso Galeota Lanza, Rosa Zampino, Evangelista Sagnelli, Giovanni Battista Gaeta, Nicola Coppola, Antonella Santonicola 2:30 PM - 4:00 PM A REAL-WORLD STUDY OF EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INHCV PATIENTS

Poster Sessions • Tuesday

536

537

538

Poster P-K1 HCV THERAPEUTICS: REALITY TESTING Poster Hall - 4EF

560

561

562

563

564

CROI 2019 75